Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.33
+0.35 (7.03%)
At close: Mar 6, 2026, 4:00 PM EST
5.30
-0.03 (-0.56%)
After-hours: Mar 6, 2026, 7:32 PM EST
Immuneering Market Cap
Immuneering has a market cap or net worth of $344.16 million as of March 6, 2026. Its market cap has increased by 548.18% in one year.
Market Cap
344.16M
Enterprise Value
175.15M
1-Year Change
548.18%
Ranking
Category
Stock Price
$5.33
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $344.16M, a decrease of -5.93%. That is a compound annual growth rate of -1.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 344.16M | -19.00% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 329.52M |
| Opus Genetics | 328.96M |
| Avalo Therapeutics | 325.45M |
| Rezolute | 325.12M |
| Relmada Therapeutics | 324.87M |
| X4 Pharmaceuticals | 323.52M |
| Shattuck Labs | 322.73M |
| Puma Biotechnology | 316.96M |